Filter By Industry
Filter By Tag

Newsroom

Immunodominant Press releases

1 - 1 of 1 Press Release

Immunodominant Announces Call for Initial Investment Round for Phase 2 Study of Of OTC COVID-19 Drug
Nov 15, 2022
Immunodominant Inc., a drug discovery and development company engaged in progressing innovative research from academia to commercialization, today announced its intention to begin an initial financing round of up to $30 million.


Immunodominant RSS Feed